Karachi: Abbott Laboratories (Pakistan) Limited has announced the re-appointment of Mr. Ehsan Ali Malik as its Chairman for a duration of three years. The appointment, which was confirmed on May 28, 2026, will see Mr. Malik at the helm of the company as it navigates its strategic objectives in the healthcare sector.
The decision to re-appoint Mr. Malik, whose leadership has been pivotal in steering the company’s operations, reflects the board’s confidence in his capabilities to lead Abbott Laboratories (Pakistan) Limited through its forthcoming initiatives and challenges. The re-appointment is effective from the end of May this year, ensuring continuity in the company’s leadership.
According to information available from the Pakistan Stock Exchange (PSX), Abbott Laboratories (Pakistan) Limited remains a significant player in the designated market category, with its activities closely monitored by investors and stakeholders. The re-appointment of Mr. Malik is anticipated to influence the company’s strategic direction and operational performance positively.
Stakeholders and TRE Certificate Holders of the Exchange have been informed of this development, marking a significant event in the corporate landscape of the country’s healthcare industry.